Meyka Pro is live. Get 50% off your first 3 months.Get Started →
Meyka Pro banner
Hyperfine, Inc.

Hyperfine, Inc. (HYPR) Stock Overview

Explore Hyperfine, Inc.’s financial performance, market position, analyst ratings, and future outlook.

HYPR●NASDAQ
HealthcareMedical - Devices
$0.90
$0.002(0.22%)
U.S. Market opens in 39h 23m

Hyperfine, Inc. (HYPR)

Meyka AI Score

Z

Key Financials

Market Cap76M
P/E Ratio-2.37
EPS (TTM)$-0.37
ROE-1.00%
Fundamental Analysis

AI Price Forecasts

1 Month$1.02
3 Months$1.55
1 Year Target$1.34

HYPR Stock Analysis & Investment Overview (NASDAQ)

Our AI-powered analysis of Hyperfine, Inc. (NASDAQ: HYPR) gives investors deep insight into how the stock performs on the NASDAQ exchange, its growth potential, and its market positioning. With a Meyka AI Score of B+, Hyperfine, Inc.'s NASDAQ-listed shares demonstrate moderate investment characteristics based on our machine learning models.

The current technical analysis of HYPR on the NASDAQ shows an RSI of 35.58, suggesting the stock is in a a neutral condition. Our forecasting models predict a 12-month price target of $1.34 for the NASDAQ listing.

Key metrics behind Hyperfine, Inc.'s NASDAQ-traded stock include a P/E ratio of -2.37 and a market capitalization of 76M. Combined with our AI analysis, these give both institutional and retail investors a clear view of HYPR on the NASDAQ.

Price Performance (NASDAQ: HYPR)

1-Day Change
-0.22%
5-Day Change
-0.34%
1-Month Change
-9.01%
3-Month Change
-39.86%
6-Month Change
-21.56%
Year-to-Date (YTD) Change
-7.88%
1-Year Change
-26.66%
3-Year Change
-63.03%
5-Year Change
-90.89%
All-Time (Max) Change
-90.99%

Contact Information

https://www.hyperfinemri.com
203-458-7100
351 New Whitfield Street, Guilford, CT, 06437

Company Facts

1,020 Employees
IPO DateJan 28, 2021
CountryUS
Actively Trading

Frequently Asked Questions